Nivolumab Therapeutic Cheat Sheet
NivolumabNivolumab, a programmed death-1 (PD-1) immune checkpoint inhibitor, is a cornerstone in the evolving field of immuno-oncology. Originally developed for advanced cancers, nivolumab functions by blocking PD-1–mediated immune suppression, thereby enhancing T-cell–mediated antitumor responses. In dermatology, its relevance has grown not only because of its utility in melanoma treatment and cutaneo …
Nivolumab
Patient Buzz Series: Tightened Rules Could Impact Marines With PFB
pseudofolliculitis barbae (PFB)The U.S. Marine Corps’ tightened shaving rules could impact its service members with pseudofolliculitis barbae (PFB), according to NBC News. Guidance issued in March says that a service member may be discharged from the Marines if PFB persists within a year while under a four-part treatment plan. Previously, Marines with PFB resistant to topical treatment were able to receive temporary or perman …
pseudofolliculitis barbae (PFB)
Patient Buzz: Eczema-Related Pigmentary Changes | The Expert Weighs In
Pigmentary ChangesA recent Allure article addressed pigmentary changes that can occur after an eczema flare in patients with skin of color. The resulting hyperpigmentation or hypopigmentation can be more frustrating to patients than eczema itself. I interviewed Rebecca Vasquez, MD, FAAD, associate professor with the UT Southwestern Medical Center Department of Dermatology. Dr. Vasquez will present on the miscel …
Pigmentary Changes
Playing by the Rules: Demystifying the Landscape of Cosmetic and Drug Regulatory Classifications in Dermatology
OTCIf you have ever wondered how an ingredient progresses from the laboratory bench to the beauty aisle, or why some products make bold efficacy claims while others remain vague, the field of regulatory affairs is the answer. Acting as the bridge between product innovation and the FDA, regulatory professionals ensure that skin care products of all kinds are compliant with U.S. law. In this session at …
OTC
JDD Buzz Series | AI in Dermatology Residency Applications
AI in dermatologyThe use of artificial intelligence (AI) programs such as ChatGPT is a source of controversy in academia, including in the college admissions process. Are applicants for dermatology residency programs using AI to write or enhance their personal statements, and if so, to what extent? A study published in the May Journal of Drugs in Dermatology found a significant increase in AI usage in dermatology …
AI in dermatology